INDSWFTLAB
1 call
Concalls & earnings callsInd-Swift Laboratories Limited
Every summarised call, newest first. Latest is Q1 FY27, held 20 Aug 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →The company delivered strong financial performance driven by its transformation into a focused FDF manufacturer, with new CDMO partnerships commercialized and sharp margin expansion.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Operating Income | ₹186.08 Cr | 21.16% | |
| Operating EBITDA | ₹33.32 Cr | 2.85x | |
| Operating EBITDA Margin | 17.91% | 1258 bps | |
| PAT (excluding exceptional item) | ₹24.68 Cr | 2.04x |
Latest guidance
- Expect incremental revenue of ₹200-220 crore from new CDMO partnerships over two years.
- Target export sales of ₹750 crore in FY27, with 45% from CDMO business.
- Expect EBITDA margins to be sustainable at 18% and potentially increase to 21-22% with sales growth.
- Revenue target of ₹1200 crore by FY29.
- Long-term vision for FY30 is revenue of ₹1500 crore and net profit of approx. ₹200+ crore.
- Capex of ₹250 crore to be deployed over 2.5 years.
- Dossiers filed expected to increase from 2,100+ to 2,500+ by Q4 FY27.
Said on the Q1 FY27 call.
Filed results
Reported quarterly history
From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.
| Quarter | Revenue | Net profit (PAT) | Basic EPS |
|---|---|---|---|
| Q3 FY25 | ₹8.66 Cr-97% YoY-27.6% QoQ | ₹0.01 Cr-99.9% YoY-97.6% QoQ | ₹0.00-100% YoY-100% QoQ |
| Q2 FY25 | ₹11.96 Cr-95.9% YoY-63.9% QoQ | ₹0.41 Cr-98.7% YoY-56.4% QoQ | ₹0.07-98.7% YoY-56.2% QoQ |
| Q1 FY25 | ₹33.17 Cr-89.3% YoY-91.6% QoQ | ₹0.94 Cr-94.5% YoY-99.6% QoQ | ₹0.16-94.5% YoY-99.6% QoQ |
| Q4 FY24 | ₹393.33 Cr+29.3% YoY+36.8% QoQ | ₹238.87 CrTurned profitable YoY+1130% QoQ | ₹40.42Turned positive YoY+1128.6% QoQ |
| Q3 FY24 | ₹287.51 Cr-8.1% YoY-0.8% QoQ | ₹19.42 Cr-29.4% YoY-38.7% QoQ | ₹3.29-29.2% YoY-38.6% QoQ |
Call history
- Q1 FY27Positive tone
The company delivered strong financial performance driven by its transformation into a focused FDF manufacturer, with new CDMO partnerships commercialized and sharp margin expansion.
- Operating Income
- ₹186.08 Cr21.16%
- Operating EBITDA
- ₹33.32 Cr2.85x